Deepar Pharmaceuticals

Pharmaceutical manufacturing and distribution of various health products in India.

About Deepar Pharmaceuticals

Deepar Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing and distribution of various health products in India. Its Indian entity Deepar Pharmaceuticals Private Limited reported revenue of β‚Ή8.30 Cr. Deepar Pharmaceuticals offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medications and Medical Supplies.

Company details

Deepar Pharmaceuticals is recognized as a pharmaceutical company that was founded in 2009 and incorporated in 2016, with a focus on delivering innovative molecules to enhance healthcare in India. The company is led by its directors who have worked to build strong relationships with doctors and provide quality, affordable medicines. Products such as tablets, capsules, and syrups are manufactured under WHO and GMP certifications, ensuring adherence to high standards. A pan-India presence is maintained to make healthcare solutions accessible, emphasizing quality assurance and customer-focused approaches in operations.

Key Metrics
  • Indian entity revenue
    ₹8.30 Cr

    FY 2025 · +6% YoY

  • Indian entity net profit
    ₹12.4 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹36.2 Lakh

    FY 2025 · 4% margin

Products & Services of Deepar Pharmaceuticals

Deepar Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules.

Tablets
Pharmaceutical Products

Various tablets are manufactured for addressing health needs, including products like LIZO-600mg Tab and SENIFER-XT Tab

Capsules
Pharmaceutical Products

Capsules are produced for medicinal purposes, such as FUNGI 200mg Cap and SENOXY Cap

Board of directors of Deepar Pharmaceuticals Private Limited (Deepar Pharmaceuticals)

Deepar Pharmaceuticals Private Limited is the primary company behind Deepar Pharmaceuticals. The board of Deepar Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Nishant Arora, appointed in 2016.

DirectorDesignationAppointedTenureEntity
Nishant Arora
DIN 07494203
Director05 May 201610 yrs 6 moDeepar Pharmaceuticals Private Limited
Sanjay Bansal
DIN 07494117
Director05 May 201610 yrs 6 moDeepar Pharmaceuticals Private Limited
Nisha
DIN 07494157
Director05 May 201610 yrs 6 moDeepar Pharmaceuticals Private Limited
Shradha Arora
DIN 07494153
Director05 May 201610 yrs 6 moDeepar Pharmaceuticals Private Limited

Financials of Deepar Pharmaceuticals

Figures of Deepar Pharmaceuticals Private Limited, the primary company behind Deepar Pharmaceuticals, for FY 2025. Revenue was ₹8.30 Cr (+6% year on year). Net profit was ₹12.4 Lakh (1% margin). EBITDA was ₹36.2 Lakh (4% margin). Revenue has grown at a compounded annual rate of -6% over three years and +3% over five years.

  • ₹8.30 CrRevenue · FY 2025 · +6% YoY
  • ₹12.4 LakhNet profit · 1% margin
  • ₹36.2 LakhEBITDA · 4% margin
  • ₹1 LakhPaid-up capital
  • -6%Revenue CAGR, 3 years
  • +3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Deepar Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Deepar Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Deepar Pharmaceuticals

The primary company behind Deepar Pharmaceuticals, Deepar Pharmaceuticals Private Limited, reported revenue of β‚Ή8.30 Cr for FY 2025, up 6% year on year.

Deepar Pharmaceuticals is recognized as a pharmaceutical company that was founded in 2009 and incorporated in 2016, with a focus on delivering innovative molecules to enhance healthcare in India. The company is led by its directors who have worked to build strong relationships with doctors and provide quality, affordable medicines. Products such as tablets, capsules, and syrups are manufactured under WHO and GMP certifications, ensuring adherence to high standards. A pan-India presence is maintained to make healthcare solutions accessible, emphasizing quality assurance and customer-focused approaches in operations.

Deepar Pharmaceuticals offers Tablets and Capsules.

Deepar Pharmaceuticals operates through Deepar Pharmaceuticals Private Limited.

The legal entities of Deepar Pharmaceuticals currently have 4 directors, including Nishant Arora, Sanjay Bansal, Nisha and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available